We are live on ! Find out more

299 hedge funds and large institutions have $5.92B invested in Qiagen in 2025 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 94 increasing their positions, 146 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital inflows, than outflows

Capital inflows: $860M | Capital outflows: $575M

46% more call options, than puts

Call options by funds: $32.9M | Put options by funds: $22.5M

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

2.7% more ownership

Funds ownership: 65.15% → 67.85% (+2.7%)

8% less funds holding

Funds holding: 325 → 299 (-26)

36% less repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 146

39% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 67

Holders
299
Holders Change
-26
Holders Change %
-8%
% of All Funds
3.99%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
41
Increased
94
Reduced
146
Closed
67
Calls
$32.9​M
Puts
$22.5​M
Net Calls
+$10.4​M
Net Calls Change
-⁠$6.64​M

QGEN Hedge Fund Activity: Q1 2025 in Review

299 of the 7,490 institutional investors tracked by Wall St. Rank reported a position in Qiagen (QGEN) for Q1 2025, worth a combined $5.92B — down 8.5% from $6.47B a quarter earlier.

Sellers outnumbered buyers: 67 funds closed out of QGEN and 41 opened new positions — a net loss of 26 holders — while 146 trimmed existing stakes and 94 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $182M. The largest seller was Jennison Associates, exiting entirely with an estimated $64.4M sold.

  • 299 institutional investors held Qiagen (QGEN) as of Q1 2025, down from 325 in Q4 2024.
  • Funds reported $5.92B of Qiagen stock for Q1 2025, down 8.5% quarter-over-quarter.
  • 41 funds opened new Qiagen positions in Q1 2025 and 67 closed out, a net change of -26 holders.
  • The largest Qiagen buyer in Q1 2025 was T. Rowe Price Associates, an estimated $182M added.
  • The largest Qiagen seller in Q1 2025 was Jennison Associates, an estimated $64.4M sold.

Based on aggregated 13F filings for Q1 2025.